BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 7972564)

  • 1. [Cortisone-induced delusional depression in systemic lupus erythematosus].
    Hatzinger M; Seifritz E; Hemmeter U; Holsboer-Trachsler E
    Psychiatr Prax; 1994 Sep; 21(5):199-203. PubMed ID: 7972564
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcome in delusional depression comparing trimipramine monotherapy with a combination of amitriptyline and haloperidol--a double-blind multicenter trial.
    Künzel HE; Ackl N; Hatzinger M; Held K; Holsboer-Trachsler E; Ising M; Kaschka W; Kasper S; Konstantinidis A; Sonntag A; Uhr M; Yassouridis A; Holsboer F; Steiger A
    J Psychiatr Res; 2009 Apr; 43(7):702-10. PubMed ID: 19038406
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Resistant depression associated with lupus erythematosus and steroid therapy.
    Benazzi F
    Can J Psychiatry; 1997 Jun; 42(5):530-1. PubMed ID: 9220120
    [No Abstract]   [Full Text] [Related]  

  • 4. [Neuropsychiatric symptoms in preventive antimalarial treatment with mefloquine: apropos of 2 cases].
    Lebain P; Juliard C; Davy JP; Dollfus S
    Encephale; 2000; 26(4):67-70. PubMed ID: 11064842
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute psychosis presenting in a patient with systemic lupus erythematosus: Questions and Answers.
    Sharma S; Lerman MA; Fitzgerald MP; Ruebner RL
    Pediatr Nephrol; 2016 Feb; 31(2):227-31. PubMed ID: 25634549
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impaired hypothalamic-pituitary-adrenocortical (HPA) system is related to severity of benzodiazepine withdrawal in patients with depression.
    Wichniak A; Brunner H; Ising M; Pedrosa Gil F; Holsboer F; Friess E
    Psychoneuroendocrinology; 2004 Oct; 29(9):1101-8. PubMed ID: 15219633
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A patient with systemic lupus erythematosus presenting both central nervous system lupus and steroid induced psychosis.
    Hirohata S; Iwamoto S; Miyamoto T; Sugiyama H; Nakano K; Inokuma S
    J Rheumatol; 1988 Apr; 15(4):706-10. PubMed ID: 3397982
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of glucocorticoids on the hypothalamic-pituitary-adrenal axis in children and adults.
    Gulliver T; Eid N
    Immunol Allergy Clin North Am; 2005 Aug; 25(3):541-55, vii. PubMed ID: 16054542
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clonazepam in the treatment of recurrent symptoms of depression and anxiety in a patient with systemic lupus erythematosus.
    Jones BD; Chouinard G
    Am J Psychiatry; 1985 Mar; 142(3):354-5. PubMed ID: 3970277
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical description and nursing of SLE (systemic lupus erythematosus). Psychological support of a female patient with pronounced dermal symptoms - a case with extensive dermatological symptoms and neurological conditions caused by steroids].
    Akai Y; Sasamoto K; Watanabe S
    Kango Gijutsu; 1982 Sep; 28(12):1585-91. PubMed ID: 6214650
    [No Abstract]   [Full Text] [Related]  

  • 11. Psychiatric disorders in Systemic Lupus Erythematosus.
    Hutchinson GA; Nehall JE; Simeon DT
    West Indian Med J; 1996 Jun; 45(2):48-50. PubMed ID: 8772393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of antidepressant drugs on the hypothalamic-pituitary-adrenal axis activity and glucocorticoid receptor function.
    Budziszewska B
    Pol J Pharmacol; 2002; 54(4):343-9. PubMed ID: 12523487
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The neuroendocrinology of stress and the pathophysiology and therapy of depression and anxiety].
    Ströhle A
    Nervenarzt; 2003 Mar; 74(3):279-91; quiz 292. PubMed ID: 12627245
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Drug-induced psychosis versus lupus-related psychosis: a report of a case].
    Hamdani N; Gorwood P; Grasland A; Ades J
    Encephale; 1999; 25(6):681-3. PubMed ID: 10668616
    [No Abstract]   [Full Text] [Related]  

  • 15. Hypothalamic-pituitary-adrenal axis suppression in systemic glucocorticoid-treated infantile hemangiomas: putting the risk into context.
    Sidbury R
    Arch Dermatol; 2009 Mar; 145(3):319-20. PubMed ID: 19289767
    [No Abstract]   [Full Text] [Related]  

  • 16. Convulsive therapy in delusional disorders.
    Fink M
    Psychiatr Clin North Am; 1995 Jun; 18(2):393-406. PubMed ID: 7659606
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Involvement and role of antidepressant drugs of the hypothalamic-pituitary-adrenal axis and glucocorticoid receptor function.
    Nikisch G
    Neuro Endocrinol Lett; 2009 Mar; 30(1):11-6. PubMed ID: 19300389
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Theory and practice with inhalation steroids--systemic effects and side effects].
    Morr H
    Pneumologie; 1991 Mar; 45(3):85-9. PubMed ID: 2031048
    [No Abstract]   [Full Text] [Related]  

  • 19. High dose methylprednisolone therapy for the treatment of severe systemic lupus erythematosus.
    Parker BJ; Bruce IN
    Lupus; 2007; 16(6):387-93. PubMed ID: 17664228
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic doses of glucocorticoids: implications for oral medicine.
    Baid SK; Nieman LK
    Oral Dis; 2006 Sep; 12(5):436-42. PubMed ID: 16910913
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.